Cime Therapeutics Inc.
BiotechnologyBiotechnology/Cell Therapy
Denver, CO
2024
founded
About
Cimeio Therapeutics is a pioneering biotechnology company established in 2020, committed to revolutionizing the treatment landscape for hematologic diseases through innovative cell therapies. The company focuses on addressing the limitations posed by traditional hematopoietic stem cell (HSC) transplantation, particularly the challenges of harsh conditioning regimens and restricted eligibility for patients.
Company Values
Cimeio stands out with its unique Shielded-Cell & Immunotherapy Pairs™ platform, which enhances the safety and accessibility of HSC transplants while minimizing the risks inherent to conventional treatments.